Agog Pharma Ltd. Rating Rationales / Reports

Title MID: 87274 12-Mar-2025 Issuer did not cooperate; Based on best available information; View Report MID: 78393 03-Mar-2025 Issuer did not cooperate; Based on best available information; Rating moved to Not Reviewed Advisory; View Report MID: 78393 28-Feb-2024 Issuer did not cooperate; Based on best available information; Outstanding Ratings Downgraded; View Report MID: 69093 06-Feb-2023 Outstanding Ratings Reaffirmed; View Report MID: 67205 03-Nov-2022 PressRelease; View Report MID: 46708 04-Nov-2021 Outstanding Ratings Reaffirmed; View Report MID: 46545 31-Dec-2020 Issuer did not cooperate; Based on best available information; Outstanding Ratings Reaffirmed; View Report MID: 35481 19-Dec-2019 Outstanding Ratings Reaffirmed; View Report MID: 26271 29-Jan-2019 Outstanding Ratings Reaffirmed; View Report MID: 19400 10-Jul-2017 Outstanding Ratings Reaffirmed; View Report MID: 13933 07-Jul-2016 Outstanding Ratings Reaffirmed; View Report MID: 7277 06-May-2015 Outstanding Ratings Reaffirmed; View Report MID: 669 12-Mar-2014 Long Term Rating BWR BB +/Stable Assigned; Short Term Rating BWR A4 + Assigned; View Report